These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 14733708)

  • 1. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
    Sharif NA; Kelly CR; Crider JY
    J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
    Sharif NA; Kelly CR; Crider JY
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
    Kelly CR; Williams GW; Sharif NA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
    Ota T; Aihara M; Narumiya S; Araie M
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cat iris sphincter smooth-muscle contraction: comparison of FP-class prostaglandin analog agonist activities.
    Sharif NA; Kaddour-Djebbar I; Abdel-Latif AA
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):152-63. PubMed ID: 18355130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys.
    Gabelt BT; Hennes EA; Bendel MA; Constant CE; Okka M; Kaufman PL
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):1-8. PubMed ID: 19232013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle.
    Romano MR; Lograno MD
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3677-82. PubMed ID: 17652738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
    Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):489-508. PubMed ID: 15684809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist.
    Hellberg MR; Sallee VL; McLaughlin MA; Sharif NA; Desantis L; Dean TR; Zinke PW
    J Ocul Pharmacol Ther; 2001 Oct; 17(5):421-32. PubMed ID: 11765147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic FP-prostaglandin-induced contraction of rat uterus smooth muscle in vitro.
    Sharif NA
    Prostaglandins Leukot Essent Fatty Acids; 2008 Mar; 78(3):199-207. PubMed ID: 18375109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.
    Sharif NA; McLaughlin MA; Kelly CR; Xu S; Crider JY; Williams GW; Parker JL
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):291-309. PubMed ID: 17076623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation.
    Sharif NA; Crider JY; Husain S; Kaddour-Djebbar I; Ansari HR; Abdel-Latif AA
    J Ocul Pharmacol Ther; 2003 Oct; 19(5):437-55. PubMed ID: 14583136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
    Bhattacherjee P; Williams BS; Paterson CA
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
    Sharif NA; Davis TL
    J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists.
    Sharif NA; Crider JY; Davis TL
    J Pharm Pharmacol; 2000 Dec; 52(12):1529-39. PubMed ID: 11197083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle.
    Krauss AH; Wiederholt M; Sturm A; Woodward DF
    Exp Eye Res; 1997 Mar; 64(3):447-53. PubMed ID: 9196397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
    Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
    Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization.
    Griffin BW; Magnino PE; Pang IH; Sharif NA
    J Pharmacol Exp Ther; 1998 Jul; 286(1):411-8. PubMed ID: 9655886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.